Key result
Rotavirus serotype G9 constituted 27% of all rotaviruses identified in children hospitalized with acute gastroenteritis in Libya, Kenya, and Cuba, highlighting its global reemergence.
Population
177 children <5 years of age hospitalized for treatment of acute gastroenteritis in Libya, Kenya, and Cuba.
Design
Cross-sectional
Authors
Loading...
Supports G9 inclusion in rotavirus vaccines; extends surveillance data but remains hypothesis-generating.
Cross-Sectional (n=177)
Yes
The detection of rotavirus serotype G9 in Libya, Kenya, and Cuba highlights its global reemergence and suggests that future rotavirus vaccines must provide protection against this serotype.
Cunliffe et al. (2001) conducted a cross-sectional in Acute gastroenteritis (n=177). Rotavirus serotype G9 vs. Other rotavirus serotypes was evaluated on Proportion of rotavirus serotype G9 among all detected rotaviruses. Rotavirus serotype G9 constituted 27% of all rotaviruses identified in children hospitalized with acute gastroenteritis in Libya, Kenya, and Cuba, highlighting its global reemergence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: